PPARG and ischemia: Pioglitazone, a peroxisome proliferator-activated receptor gamma or PPARγ agonist, was shown to prevent ischemia-induced ED in healthy subjects [56], and improve endothelial and adipose tissue dysfunction in pre-diabetic patients with coronary artery disease (CAD) [57].